SAN DIEGO–(BUSINESS WIRE)–Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements. Dr. John F. Burd, Ph.D., CEO of Lysulin, said, “Lysulin is pleased to report that we have resolved the issues raised by … [Read more…]
Connection, Partnership, & An Agent for Change NORFOLK, Va.–(BUSINESS WIRE)–Grant Lottering and Unite Health Share Ministries (UHSM), a faith-based health care nonprofit dedicated to a holistic approach to one’s health, have positively impacted children on behalf of nonprofit Laureus Sport for Good USA. Together, their missions emphasize a wellness approach that focuses on the mind-body-and-soul … [Read more…]
The $16.4 Million Development Serves People Living with HIV AUSTIN, Texas–(BUSINESS WIRE)–Prosperity Bank and the Federal Home Loan Bank of Dallas (FHLB Dallas) awarded a $750,000 Affordable Housing Program (AHP) subsidy to build an affordable apartment complex for people living with HIV in Austin, Texas. Scurry Miller, executive director of Project Transitions Inc., said stable … [Read more…]
Program helps identify biomarkers of non-small cell lung cancer and potential targeted treatments or clinical trials BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, understands the important and growing role of precision medicine and is working to ensure more people have access to targeted and personalized treatments. As part of this effort, … [Read more…]
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, effective on May 23, 2022 and May 31, 2022, respectively (the “Grant Dates”), the Compensation Committee of Precision’s Board of Directors approved the grant of inducement … [Read more…]
NEWARK, Del.–(BUSINESS WIRE)–ANP Technologies, Inc. (ANP) announced that its drug master file (DMF) on its novel, nano-encapsulating polymer-based drug excipient, ANP001B has been accepted and published by the U.S. Food & Drug Administration (FDA). The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform that can be broadly applicable … [Read more…]
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. José (Joe) Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 10:40 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at … [Read more…]
PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that its Annual Combined Shareholders General Meeting will be held on June 23, 2022 at 9.30 AM Central European Time (CET), 3.30 … [Read more…]
CAMP HILL, Pa.–(BUSINESS WIRE)–Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2023 First Quarter, which ended May 28, 2022, on Thursday, June 23, 2022. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid’s management team. The call will be … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced numerous advances in digital fluidics that will be presented at AGBT General Meeting. “We have been hard at work to develop bioautomation technology and we are excited to unveil the company and the technology at AGBT,” … [Read more…]
